Member Info for RichTheNewbie

It's worth pointing out that the $8m value, for $6m investment, is only if the raise is at the same price as previously.
Looking at a chart of average and median rises, between venture capital rounds, the median is 1.6x higher in the next round, and average is over double.
For those with an existing corporate venture capital investor like Factom the prices tend to be another notch higher.
So, if Factom only did a raise at an "average" level for the next stage, that could be double the $6m value, at a 25% discount, i.e. $16m.
You would have thought if they were asking for less money the price they could command could actually be much higher still.
Fingers crossed.

Yeah. I've been trying to think through the little information in the RNS.
I do wonder if instead of a large, and potentially more-dilutive, fundraising round, whether this low threshold of $3m actually signals they feel they don't actually need to do this, and instead can perform a smaller fundraising, potentially at a less dilutive and better price.
I do wonder about the logic of FFWD not converting.....and can't come up with much....other than perhaps FFWD will be party to the raising, and sell their shares directly as part of the transaction. Ie someone simply pays $10m, or $15m, etc, for FFWDs stake as part of the deal.

You sound like my kind of woman....

Always remember you're standing on a cool snowy mountain.......and relax.
Problem is when you wobble on that snowy mountain your wobbles can inadvertently start a mini avalanche.
So best to avoid wobbles and have a nice warming brandy and await the chopper to take you to the summit ;)

Bless you Snooty.....

I agree you generally are and keep more light hearted than most.
However you are prone to a bit of an ODONNELL wobble every time the SP falls and start trying to read into it ;)
I'm looking forward to the day, where out of the blue, LEAP is sold for a nice big wedge, and the SP starts at double/triple the price, and with all the other investments still to play for ;)

Anyway, there goes another 50k bought at 8.95p, and another 50k bought at 9p now.

Point was you probably just need to relax and take a slightly less reactionary/short-termist view chilston ;)
Just because a share pulls back a bit it doesn't suddenly mean there's no sentiment or that it's only going to drift down.

Time and again on AIM I see people selling out at the lows (or near them), for no good reason, other than they convince themselves, or get convinced, that there's no short term prospect of a rise, only for it to promptly do just that.

The drift factor is much more likely on a stock with a high cash-burn rate as it's usually ticking down to a placing to keep the lights on and only hoping for news in between stops it. Thankfully this being an investment fund, with minimal costs, it doesn't have that problem.

ODONNELL - THC is the main psychoactive component in cannabis (ie the bit that gets you high and most likely to make you go nuts). The other main component is CBD. So in theory if you were looking to use it medicinally you'd want a zero/low THC product and higher CBD component.

And....we start the day with a buy at 8.7p
Price rising back nicely.
Sorry Chilston........ we did warn your "drift" was just a bear trap ;) and as expected its swiftly back up after diddling a few silly people out of their shares!

Milk.....although it's a tea I've had really.

I think we can probably move on from what the ODONNELLs listen to on the radio.....as it's probably got about as much relevance to the share price as whether I had weetabix or a coffee this morning!

I was amazed at how the copper dumps news had made the price rise so much.
If anything it looked like they were trying to repeat the last disaster when they got involved in copper dumps. At the very least it looks like a pump for a placing and immediate dump.
Someone posted this on Twitter today.....all sounds very fishy: https://medium.com/@hannsjohn4/the-kalengwa-copper-mine-making-offers-that-can-be-refused-f28ba65cab48

The trading suggests that's right. Once the buy price dropped (after they got the one big sell) you could see the buy price steadily rising back upwards as they ran out of those shares.
Just needs small amounts of steady buying and you'll probably see it pushing back upwards towards 9p and beyond. Let's face it, you can tell by certain postings that some will have traded out, and be looking to get back in and the minute they think it's rising again, they'll be fighting each other again to do so.

Not going well though. It's being bought up still ;)

unsurprised=surprised

I would be very unsurprised if this wasn't the MM's just trying to restock their coffers.
The recent rise they'll have sold plenty to people, emptying their coffers, and I don't think there's been a mass of selling to warrant the fall and restock them.
So they probably want to iceberg the ask, make it as unappealing as possible to buy now, and hope people sell them some shares back at the lows.

That's good. Making a mess of their own markets should mean longer before they even consider branching out and being a threat to EMMAC who could be nicely entrenched by then.

Nothing really new, but FYI a FinnCap analyst put out a brief update yesterday:
"Synairgen confirmed that it is on track to complete its 120-patient Phase II trial of SNG001 (inhaled interferon beta) in COPD in the 2019/2020 winter virus season due to an increase in the number of participating UK clinical sites and an acceleration in the number of eligible patients into the pool of COPD patients. Moreover, a blinded analysis of the patients enrolled to date has shown that viral infection is having a significant detrimental impact on COPD symptoms in the trial, confirming the significant unmet need for this patient group and increasing the probability of showing a clear drug-related effect. We reiterate our target price."

Target price reiterated at 54p.

Not an unreasonable guess Kierewiet.